- Reaction score
- 132
JIMMY<3
Tissuse And J. Hewitt: Smart Hair Transplant Trial In 2019!
- Thread starter RolfLeeBuckler
- Start date
Well boys....we officially are in late 2019
Excited for December
- Reaction score
- 288
Why ?
I think because of the whole point of this thread, no?
- Reaction score
- 287
Nope, In December they'll start (if everything goes well). We won't have any trial results in December.
I get that, but what's wrong with someone being excited for the launch of the trials? It still takes manpower, money and other resources to launch a trial in the first place. It's a milestone for that company, and for the industry it means something to look forward to...
Give me a break!!!!
December 2019 is important because it will answer that question - whether they can really start their trial at that time or not.
You're right. And it's unintelligent for someone not to understand that December is an important date in this matter since J. Hewitt said they would start the trial in December. And of course the trial has to start before it can finish.
- Reaction score
- 984
The International Society of Hair Restoration Surgery is having its annual World Congress meeting on November 13 – 17 2019 in Bangkok, Thailand.
TissUse Poster
A very positive sign for anyone following the latest SHT/J.Hewitt developments, TissUse has a poster on display at this year’s ISHRS Congress titled: “Development of Hair Follicle Anagen In Vitro as a Proof for the Hair Growth Inductive Properties of Neopapilla Hair Germ Transplants Intended for ‘Hair Cloning’ – Gerd Lindner, PhD Germany”
Perhaps, following the Congress there will be an update shared about the exciting pending human trials for TissUse and J. Hewitt in Japan. Stay tuned.
--
source: folliclethought
TissUse Poster
A very positive sign for anyone following the latest SHT/J.Hewitt developments, TissUse has a poster on display at this year’s ISHRS Congress titled: “Development of Hair Follicle Anagen In Vitro as a Proof for the Hair Growth Inductive Properties of Neopapilla Hair Germ Transplants Intended for ‘Hair Cloning’ – Gerd Lindner, PhD Germany”
Perhaps, following the Congress there will be an update shared about the exciting pending human trials for TissUse and J. Hewitt in Japan. Stay tuned.
--
source: folliclethought
- Reaction score
- 1,242
When will we ever see "release" instead of "in development"
Why ask a question that obviously no one has an answer to yet
only one of those are japanese
And Tissue, Replicel have a license agreement in japan and tsuji originates from japan
i think Samumed is turkish ?
- Reaction score
- 287
Yeah, cause the timeplan is only discipline and nothing else, lol... Some of you really have not the slidest idea how science works...
- Reaction score
- 1,242
Ain't a real question, more like a
rhetorical response
- Reaction score
- 984
On which Conference in China they will
Talk?
On The Conference in Bangkok The ISHRS in Bangkok they only have a Poster.
Please give US a Link of The Conference in China.
- Reaction score
- 481
Yup, please tell us which conference.
As far as I am aware, the BIT's 13th World Congress on Regenerative Medecine and Stem Cells already took place, beginning of November
That was in 2011. I think he's confused.
- Reaction score
- 481
So ISHRS World Congress is over and we got no news from TissUse... Sadness for all my fellahs
- Reaction score
- 373
So ISHRS World Congress is over and we got no news from TissUse... Sadness for all my fellahs
TissUse only presented posterd!
- Reaction score
- 984
The poster of TissUse was never presented on the Congress.
And the next bad news out of this bastard industry:
TissUse is the planned trial with J. Hewitt which is now looking to take place in January. J Hewitt is still committed to the trial and it looks like they will be the first next-gen cell therapy company to get into a clinical trial. December was the plan but the CEO had been in negotiations with a company who is going to carry out the actual trial, a cell processing center in Japan.
And the next bad news out of this bastard industry:
TissUse is the planned trial with J. Hewitt which is now looking to take place in January. J Hewitt is still committed to the trial and it looks like they will be the first next-gen cell therapy company to get into a clinical trial. December was the plan but the CEO had been in negotiations with a company who is going to carry out the actual trial, a cell processing center in Japan.